http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-035226-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-90
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10
filingDate 2002-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c80c9f80ba98542a43971f39b38c54a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8e4fe2ce516b7275eb7d4af96d12634
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b42da9fdcb986054f84644a3aa50f4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0294353568e214ef4fa97bd125cca662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_662b602b6d999dc8065bb81e9c69142a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b4067d2cfe96814c23e385e26366398
publicationDate 2004-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-035226-A1
titleOfInvention DERIVATIVES OF RENT-PHENYLIMINE-IMIDAZOLIDINE FOR THE TREATMENT OF URINARY INCONTINENCE.
abstract M-alkyl-phenylimino-imidazolidine derivatives with a new model of substituents on the phenyl ring and their use for the preparation of medications, in particular for the treatment of urinary incontinence. Claim 1: Compound of general formula (1) wherein R1 or R5 are, independently of one another, H, F, Cl, Br, CH2F, CHF2, CF3, Me or OMe; R2 and R4 are, in each case independently of each other, H, branched C3-6 alkyl, F, Cl, Br, CH2F, CHF2, CF3 or Me, with at least one of the radicals R2 or R4 being C3-6 alkyl branched; and R3 is H, F, Cl, Br, CH2F, CHF2, CF3 or Me; and / or a physiologically acceptable salt, as well as the corresponding tautomeric forms of the compounds according to formula (2) and / or a pharmacologically acceptable salt thereof.
priorityDate 2001-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811

Total number of triples: 22.